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Abstract
Historically, concerns with fish consumption have addressed risks from contaminants (e.g.,
methylmercury (MeHg), and PCBs). More recently public health concerns have widened in
appreciation of the specific benefits of fish consumption such as those arising from polyunsaturated
fatty acids (PUFAs) in fish oil. Fish contains varying levels of PUFAs and MeHg. Since both address
the same health outcomes (in opposite directions) and occur together in fish, great care must be
exercised in providing public health guidance. Mozaffarian and Rimm in a recent article (JAMA.
2006, 296:1885–99) have made a strong case for the beneficial effects of PUFAs in reducing the
risk of coronary heart disease, but at the same time, have also broadly discounted the increased
risks of coronary heart disease posed by MeHg in fish, stating that "... among adults... the benefits
of fish intake exceed the potential risks." This conclusion appears to be based on an inaccurate and
insufficiently critical analysis of the literature. This literature is re-examined in light of their
conclusions, and the available and appropriate public health options are considered.
Background
During the past 15 years or so, public health concerns
regarding fish consumption have tended to focus mostly
on the risks associated with contaminants such as methyl-
mercury (MeHg) and PCBs in fish. More recently, recogni-
tion of the general and specific nutritional benefits
provided by fish, particularly polyunsaturated fatty acids
(PUFA, omega-3 fatty acids (n-3 fatty acids) has appropri-
ately widened the public health focus to include the pub-
lic health benefits of fish consumption. The potential for
both risks and benefits arising from the same food source
begs for an overall assessment and ultimately a balancing
of risks and benefits in public health guidance. This is all
the more so because the major potential health risks of
concern, neurodevelopmental effects and cardiovascular
effects are precisely the areas where the potential benefits
may also occur. This unusual state of affairs means that
great care must be exercised in providing public health
guidance. It also places a considerable burden on those
who would advocate significant changes in existing guid-
ance. In their relatively recent review paper in JAMA [1],
Mozaffarian and Rimm make a strong case for beneficial
effects of fish-based polyunsaturated fatty acids (PUFA)
per se, particularly with respect to their apparent reduction
in the risk of coronary heart disease. However, I believe
that they did not give adequate consideration to the
increased risks of coronary heart disease posed by the
MeHg in fish, and their broad conclusion that "... among
adults... the benefits of fish intake exceed the potential
risks" therefore constitutes inappropriate and potentially
misleading public health guidance.
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The case that Mozaffarian and Rimm present for the ben-
eficial effects of PUFAs in providing protection against
coronary heart disease is seen most strongly in the studies
represented in Figs. 1 and 2 of their paper. However, their
analysis addresses only part of the public health issues
connected with fish consumption. A closer analysis of
their data raises serious questions about whether their
analysis of the cardiovascular risks and benefits of fish
consumption take both PUFAs and methylmercury into
account as opposed to merely addressing PUFA intake in
isolation. Many of the data in the studies they analyze
reflect studies in which subjects consumed purified fish
oil. To the extent that some of these studies, in fact, reflect
fish intake, it is not clear that they also reflect significant
MeHg intake. Higher levels of PUFA intake (in studies of
fish consumption) do not necessarily reflect increased fish
intake and, by extension, do not necessarily imply higher
levels of MeHg intake, but may simply reflect, instead,
intake of fish species with higher PUFA content. Oily fish
(i.e., those high in PUFAs) are not characteristically also
high in Hg. This can be seen in the data for commonly
consumed species of fish presented in Table 2 of the
Mozaffarian and Rimm paper and shown here (minus cat-
fish and trout, which are not ocean fish) in Figure 1
(author's rendition).
This figure shows that fish with high PUFA content are not
particularly high in Hg, and the fish with the highest Hg
concentration (shark, swordfish, tilefish) do not have par-
ticularly high levels of PUFA. It is also worth noting that
these particular species of fish do not account for a signif-
icant portion of national fish consumption [2]. Thus, it is
likely that for studies analyzed by Mozaffarian and Rimm
that quantified PUFA intake on the basis of fish consump-
tion, MeHg intake was, on average, low, especially for that
portion of the cohort with high PUFA intakes. Thus, these
observations probably do not tell us much about the car-
diovascular risk for those fish consumers with elevated
MeHg intakes and moderate or even high PUFA intakes.
Without focusing on the subset of the population with
elevated MeHg intakes, or without applying a case-control
approach and starting with those who experienced coro-
nary events, we don't know much about the interaction of
PUFAs and MeHg. This can only be done in studies that
examine the association of both PUFAs and MeHg with
cardiovascular risk.
The number of studies that do examine both the PUFAs
and MeHg in relation to cardiovascular outcome is rela-
tively small. In their paper, the authors state: "Several
studies have evaluated the relationship between mercury
exposure and incidence of cardiovascular disease. The
conflicting results provide inconclusive evidence for cardi-
ovascular toxicity of mercury. Notably, in the two studies
observing higher risk with higher mercury levels, the net
effect of fish consumption was still beneficial: greater mer-
cury exposure lessened the benefit associated with con-
sumption of fish or n-3 PUFAs, but did not increase
overall risk." The studies cited in support of this statement
are clearly not all of equal quality or applicability. Of the
five studies cited [3-7], two, Hallgren et al. [3] and Ahl-
qwist et al. [3], are not comparable to the others. The Hall-
gren et al. study included only 78 MI cases compared to
684 in the Guallar et al. study [5], 470 CHD cases in the
Yoshizawa et al. study [5], and 282 acute coronary event
cases plus 132 cardiovascular disease cases in the Virtanen
et al. study [6]. In the high-Hg – low-PUFA group in Hall-
gren et al., there were only 4 cases. Thus, the Hallgren et
al. study had relatively less power to see either MeHg
effects per se, or to evaluate the interaction of PUFAs and
MeHg. Hallgren et al. used MeHg and PUFA exposure data
that were collected up to 10 years prior to the case identi-
fications. This increases the potential for exposure mis-
classification and makes identification of a true
association less likely. Furthermore, the Hallgren et al.,
and Ahllqwist et al. studies were the only studies under
consideration that included women. The Ahlqwist et al.
study is particularly problematic for assessing the associa-
tion of MeHg, PUFA and cardiovascular outcomes. The
study involved only women. Hg concentration was deter-
mined in serum only, and thus, as the authors of that
study note, disproportionally reflects inorganic Hg expo-
sure (e.g., from dental amalgams) rather than MeHg expo-
sure. Neither Hg concentrations, nor fish consumption
data are actually reported. Furthermore, for most subjects,
the Hg exposure data were collected up to 25 years prior
to case identification. Thus, of the five studies cited by
Mozaffarian and Rimm as addressing the association
Mercury and PUFA (EPA+DHA) in commonly consumed ma ine fishFigur  1
Mercury and PUFA (EPA+DHA) in commonly con-
sumed marine fish. Based on Table 2 of Mozaffarian and 
Rimm [1] (excluding catfish and trout, which are not marine 
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itive, and of the three negative studies, two are not high
quality studies for this purpose and should not have been
considered. The remaining negative study, Yoshizawa et
al. [7], is a high quality study. However, as the authors of
that paper discuss, the results are potentially confounded
by the presence of the dentists among the health profes-
sionals. The dentists constitute the majority of the sub-
jects, and their exposure to elemental Hg dominates their
overall Hg exposure. The Yoshizawa et al. study can rea-
sonably be considered equivocal with respect to MeHg
expsosure per se. Thus, Mozaffarian and Rimm misstate
the case in stating that "the conflicting results provide
inconclusive evidence for cardiovascular toxicity of mer-
cury" While I would agree that the positive evidence is not
completely conclusive, the negative evidence is weak, Fur-
thermore, the two positive studies, Guallar et al. and Vir-
tanen et al., are, in fact, more persuasive than might be
inferred from a simple count of citations. The Guallar et
al. study is a large multi-center study that incorporates
data from geographically diverse communities with differ-
ent types of fish consumption, different levels of MeHg
and PUFA intake, different overall diets and different life-
style characteristics. No one center dominated the results,
and elimination of the two centers with the highest MeHg
exposure did not alter the findings. In addition, in the
Guallar study, Hg exposure data (toenails) were collected
in close proximity to the first myocardial infarction. Expo-
sure data are therefore closely temporally linked to the
outcome. The Virtanen et al. study is a prospective study
with a study cohort of 1,871. This study represents an
analysis of an extended follow-up period for a cohort in
which a relationship between MeHg exposure and acute
coronary events had been previously been observed [8,9].
MeHg exposure was estimated from hair Hg concentra-
tion, a well-validated biomarker for MeHg exposure.
Based on the data provided for average follow-up time
and the dates of hair sampling, hair samples for Hg were
obtained at about the mid-point of the entire range of the
follow-up period, and most of the samples appear to have
been taken within 4–5 years of an acute coronary event.
The findings in this cohort have been consistent across
studies and follow-up periods.
Even more critical, however, from the standpoint of influ-
encing public health policy is the assertion by Mozaffarian
and Rimm that: "Notably, in the two studies observing
higher risk with higher mercury levels [Guallar et al., and
Virtanen et al.], the net effect of fish consumption was still
beneficial: greater mercury exposure lessened the benefit
associated with consumption of fish n-3 PUFAs, but did
not increase overall risk." I can find no basis of support for
that statement. Rather, in their Table 4, Guallar et al. show
that without adjustment for DHA (i.e., when both Hg and
DHA exposure are considered together), the odds-ratio for
MI increases dramatically in the highest quintile of Hg
exposure (1.0–1.47, p for trend = 0.01). While without
adjustment for Hg (again considering Hg and DHA expo-
sure together), the odds-ratio for MI does not differ across
the quintiles of DHA (1.0-0.8, p for trend = 0.23). That is,
DHA is not protective against the increased risk of MI due
to Hg exposure. A downward trend in the odds-ratio with
increasing DHA is only seen after controlling for Hg expo-
sure. That is, only when the effect of Hg is held constant
across levels of DHA exposure is an underlying protective
effect of DHA seen. Likewise, in Tables 2 and 3 of Virtanen
et al., the authors report that without adjustment for
DHA+DPA (i.e., considering both the PUFAs and Hg), the
relative risk for acute coronary events in men in the upper
third of Hg exposure is increased 55–60% compared to
men in the lowest third of exposure. Furthermore, the rel-
ative risk of acute coronary events with increasing
DHA+DPA does not extend below 1.0 when hair Hg con-
centration exceeds 2.03 ppm (the upper third of the distri-
bution of hair Hg concentration in the study population).
These results show that in this population, when Hg
intake was moderately elevated, Hg increased the risk of
an acute coronary event and that risk was not offset by the
PUFA intake.
The broad conclusion of Mozaffarian and Rimm that "...
among adults... the benefits of fish intake exceed the
potential risks," appears to rest on the assertions that there
is no clear evidence for adverse effects of MeHg at current
levels of intake from fish consumption, and that any
increase in risk that might be present from MeHg intake
from fish consumption is more than offset by the concur-
rent PUFA intake. Based on the foregoing, I am at a loss to
see how the data support such an unequivocal statement.
The results from both Virtanen et al., and Guallar et al.
show a clear increase the risk of acute coronary events
with moderately increased MeHg intake. Furthermore,
Virtanen et al. in their Table 3, present evidence for an
interaction between the beneficial effects of PUFA intake
and the risks from MeHg intake (relative risk of acute cor-
onary event per unit increase in DHA+DPA stratified by
low and high hair Hg = 0.69 and 1.06 respectively, p value
for interaction = 0.023), such that at moderate levels of
MeHg intake, not only does MeHg risk increase, but PUFA
benefit decreases, with the result that the risk outweigh
the benefits. This is by no means to say that people should
avoid fish. Eating fish, or not eating fish, is not the rele-
vant choice, and not the appropriate public health issue.
Rather, the data presented by Mozaffarian and Rimm in
their Table 2 shows there is a variety of easily available fish
that offers high PUFAs and low MeHg. In fact, even if one
considers fish consumption at the 12 ounces per week
(340 g/week) recommended by the U.S.FDA specifically
for women of childbearing age on the basis of MeHg
developmental risk to the fetus [10] rather than at thePage 3 of 4
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likely less restrictive rate that would be appropriate for
adult men, about half the commonly consumed fish and
shellfish in Mozaffarian and Rimm's Table 2 would meet
the criterion of providing the 250 mg/day of EPA and
DHA they identify as the target to reduce coronary heart
disease and having Hg concentrations characterized by
FDA as suitable for regular consumption. This pattern is
also seen in the more comprehensive database presented
by Mahaffey [11]. It is also worth noting in this context
that there are other dietary sources of omega-3 PUFAs
such as flaxseed oil, canola oil, and soybean oil as well as
refined fish oil [12]. While these may provide alternatives
for those who are not amenable to regular consumption
of fish, I believe that the overall nutritional benefits of fish
make consumption of high PUFA-low Hg fish the most
desirable option at the present time.
Conclusion
That there are easily available fish that offer both high
PUFA and low MeHg and that consumers should choose
wisely among the available fish so as to maximize the ben-
efit and decrease the risks is, I believe, the appropriate
public health message. The overly broad and thus unsup-
portable statement by Mozzaffarian and Rimm that "...
among adults... the benefits of fish intake exceed the
potential risks" is, given the available data, an inappropri-
ate public health message.
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